Raltegravir is a substrate for SLC22A6: A putative mechanism for the interaction between raltegravir and tenofovir
(2011)
Journal Article
(2011). Raltegravir is a substrate for SLC22A6: A putative mechanism for the interaction between raltegravir and tenofovir. Antimicrobial Agents and Chemotherapy, 879-887. https://doi.org/10.1128/AAC.00623-10
The identification of transporters of the HIV integrase inhibitor raltegravir could be a factor in an understanding of the pharmacokinetic-pharmacodynamic relationship and reported drug interactions of raltegravir. Here we determined whether raltegr... Read More about Raltegravir is a substrate for SLC22A6: A putative mechanism for the interaction between raltegravir and tenofovir.